Zhi Hong
Chief Executive Officer chez BRII BIOSCIENCES LIMITED
Fortune : 4 M $ au 31/03/2024
Profil
Zhi Hong is the Chairman and CEO of Brii Biosciences Ltd.
and Brii Biosciences Ltd.
(China), both of which he founded in 2018 and 2017 respectively.
He is also the founder of Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Dr. Hong's current positions include Chairman at Brii Biosciences (Beijing) Co. Ltd., and Director at Brii Biosciences Offshore Ltd.
and Brii Biosciences (Hong Kong) Co. Ltd.
Dr. Hong's former positions include CEO and Director at Brii Biosciences, Inc., Independent Director at Anacor Pharmaceuticals LLC, Director at ViiV Healthcare Ltd., Vice President and Head-Research at Bausch Health Americas, Inc., Senior Vice President at GSK Plc, and Chief Scientific Officer and EVP-Research at Ardea Biosciences, Inc. Dr. Hong holds a doctorate from the State University of New York at Buffalo and The State University of New York, and an undergraduate degree from Fudan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BRII BIOSCIENCES LIMITED
4,44% | 22/09/2023 | 32 400 000 ( 4,44% ) | 4 M $ | 31/03/2024 |
Postes actifs de Zhi Hong
| Sociétés | Poste | Début |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Chief Executive Officer | 23/02/2018 |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
| Brii Biosciences (Beijing) Co. Ltd. | Chairman | 01/02/2019 |
| Brii Biosciences Offshore Ltd. | Director/Board Member | 01/05/2018 |
| Brii Biosciences (Hong Kong) Co. Ltd. | Director/Board Member | 01/11/2018 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Chief Executive Officer | 01/01/2018 |
Anciens postes connus de Zhi Hong
| Sociétés | Poste | Fin |
|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Director/Board Member | 15/03/2018 |
| GSK PLC | Corporate Officer/Principal | 01/03/2018 |
| ANACOR PHARMACEUTICALS INC | Director/Board Member | 25/05/2011 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Zhi Hong
| State University of New York at Buffalo | Doctorate Degree |
| The State University of New York | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GSK PLC | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Entreprise privées | 10 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Health Technology |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
| Brii Biosciences, Inc. | |
| Brii Biosciences (Beijing) Co. Ltd. | |
| Brii Biosciences Offshore Ltd. | |
| Brii Biosciences (Hong Kong) Co. Ltd. |
